Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease

DNA and Cell Biology

Volumn 28, Issue 5, 2009, Pages 265-269

  Araüjo, Ana Paula ^a,b   Ribeiro, Ricardo ^a,c   Pinto, Daniela ^a   Pereira, Deolinda ^a   Sousa, Berta ^a   Mauricio, Joaquina ^a   Lopes, Carlos ^c   Medeiros, Rui ^a,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BREAST TUMOR; COLLOID CARCINOMA; GENETICS; LUNG CARCINOMA; METABOLISM; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

MAMMALIA;

ADENOCARCINOMA, MUCINOUS; ADULT; AGE OF ONSET; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 65549171488     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0823     Document Type: Article

References (41)

1. Amend, K.L., Elder, J.T., Tomsho, L.P., Bonner, J.D., Johnson, T.M., Schwartz, J., Berwick, M., and Gruber, S.B. (2004). EGF gene polymorphism and the risk of incident primary mela-noma. Cancer Res 64, 2668-2672. (Pubitemid 38500598)
2. Araujo, A., Ribeiro, R., Azevedo, 1., Coelho, A., Soares, M., Sousa, B., Pinto, D., Lopes, C, Medeiros, R., and Scagliotti, G.V. (2007). Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer-a review of the literature. Oncologist 12, 201-210. (Pubitemid 46271622)
3. Arteaga, C.L. (2001). The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 19, 32s-40s.
4. Beardmore, J.M., and Richards, R.C. (1983). Concentrations of epidermal growth factor in mouse milk throughout lactation. J Endocrinol 96, 287-292. (Pubitemid 13138083)
5. Bhowmick, D.A., Zhuang, Z Wait, S.D., and Weil, R.J. (2004). A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64,1220-1223. (Pubitemid 38235584)
6. Brown, C.F., Teng, C.T., Pentecost, B.T., and DiAugustine, R.P. (1989). Epidermal growth factor precursor in mouse lactat- ing mammary gland alveolar cells. Mol Endocrinol 3, 1077-1083. (Pubitemid 19197801)
7. BubliL E.M., and Yarden, Y. (2007). The EGF receptor family: spearheading a merger of signalling and therapeutics. Curr Opin Cell Biol 19, 124-134. (Pubitemid 46386405)
8. Ciardiello, F., and Tortora, G.A. (2001). Novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7, 2958-2970. (Pubitemid 32963812)
9. Costa, B.M., Ferreira, P., Costa, S., Canedo, P., Oliveira, P., Silva, A., Pardal, R, Suriano, G., Machado, J.C., Lopes, J.M., and Reis, R.M. (2007a). Association between functional EGF + 61 polymorphism and glioma risk. Clin Cancer Res 13, 2621-2626. (Pubitemid 46788028)
10. Costa, S., Pinto, D., Pereira, D., Rodrigues, H., Cameselle- Teijeiro, J., Medeiros, R., and Schmitt, F. (2007b). DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103, 209-217. (Pubitemid 46789140)
11. Costa, S., Pinto, D., Pereira, D., Rodrigues, FL, Cameselle- Teijeiro, J., Medeiros, R., and Schmitt, F. (2008). Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8, 32.
12. Dehnhard, M., Claus, R., Munz, O., and Weiler, U. (2000). Course of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) in mammary secretions of the goat during end-pregnancy and early lactation. J Vet Med A Physiol Pathol Clin Med 47, 533-540.
13. Fisher, D.A., and Lakshmanan, J. (1990). Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11, 418-442. (Pubitemid 20261694)
14. Friedman, L.M., Rinon, A., Schechter, B., Lyass, L., Lavi, S., Bacus, S.S., Sela, M., and Yarden, Y. (2005). Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc Natl Acad Sci USA 102, 1915-1920 (Pubitemid 40261987)
15. Goustin, A.S., Leof, E.B., Shipley, G.D., and Moses, H.L. (1986). Growth factors and cancer. Cancer Res 46, 1015-1029. (Pubitemid 16048224)
16. Hamai, Y., Matsumura, S., Matsusaki, K., Kitadai, Y., Yoshida, K, Yamaguchi, Y., Imai, K., Nakachi, K., Toge, T., and Yasui, W. (2005). A single nucleotide polymorphism in the 5' un-translated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology 72, 133-1118 (Pubitemid 40674996)
17. Henson, E.S., and Gibson, S.B. (2006). Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18, 2089-2097. (Pubitemid 44642342)
18. Hoibro, T, and Hynes, N.E. (2004). ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44, 195-217. (Pubitemid 38263839)
19. Hoibro, T., Civenni, G., and Hynes, N.E. (2003). The ErbB receptors and their role in cancer progression. Exp Cell Res 284, 99-110. (Pubitemid 36331969)
20. Johnson, H.M., Subramaniam, P.S., Olsnes, S., and Jans, D.A. (2004). Trafficking and signalling pathways of nuclear localizing protein ligands and their receptors. Bioessays 26, 993-1004. (Pubitemid 39273072)
21. Lenferink, A.E., Pinkas-Kramarski, R., van de Poll, M.L., van Vugt, M.J., Klapper, L.N., Tzahar, E., Waterman, H., Sela, M., van Zoelen, E.J., and Yarden, Y. (1998). Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J 17, 3385-3397. (Pubitemid 28279512)
22. McCarron, S.L., Bateman, A.C., Theaker, J.M., and Howell, W.M. (2003). EGF + 61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107, 673-675. (Pubitemid 37296132)
23. Medeiros, R., Soares, R., Vasconcelos, A., Schmitt, F., and Lopes, C. (2004a). Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis 7, 53-58. (Pubitemid 39127771)
24. Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Lobo, F., Morais, A., Oliveira, J., and Lopes, C. (2004b). Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202, 330-335. (Pubitemid 38325242)
25. Moran, J.R., Courtney, M.E., Orth, D.N., Vaughan, R., Coy, S., Mount, CD., Sherrell, B.J., and Greene, H.L. (1983). Epidermal growth factor in human milk: daily production and diurnal variation during early lactation in mothers delivering at term and at premature gestation. J Pediatr 103, 402-405.
26. Mosesson, Y., and Yarden, Y. (2004). Oncogenic growth factor receptors: implications for signal transduction therapy. Semin Cancer Biol 14, 262-270. (Pubitemid 38824587)
27. Parkin, D.M., Bray, R, Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108. (Pubitemid 40372904)
28. Rees, J. (2002). Functional polymorphism in EGF gene and malignant melanoma. Lancet 360, 570. (Pubitemid 35232118)
29. Ribeiro, R., Soares, A., Pinto, D., Catarino, R., Lopes, C, and Medeiros, R. (2007). EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neuro fibromatosis type 1 patients. J Neurooncol 81, 225-229. (Pubitemid 46165324)
30. Rosfjord, E.C., and Dickson, R.B. (1999). Growth factors, apo- ptosis, and survival of mammary epithelial cells. J Mammary Gland Biol Neoplasia 4, 229-237.
31. Roskoski, R. (2004). The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 319,1-11. (Pubitemid 38670153)
32. Russo, J., Moral, R., Balogh, G.A., Mailo, D., and Russo, I.H. (2005). The protective role of pregnancy in breast cancer Breast Cancer Res 7, 131-142. (Pubitemid 40704134)
33. Salazar, G., and Gonzalez, A. (2002). Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol Biol Cell 13,677-1693. (Pubitemid 34522648)
34. Salomon, D.S., Brandt, R., Ciardiello, F., and Normanno, N. (1995). Epidermal growth factor-related peptides and their receptors in human malignancies crit Rev Qncol Hematol 19, 183-232.
35. Shahbazi, M., Pravica, V., Nasreen, N., Fakhoury, H., Fryer, A.A., Strange, R.C., Hutchinson, P.E., Osborne, J.E., Lear, J.T., Smith, A.G., and Hutchinson, IV. (2002). Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359, 397-401. (Pubitemid 34158948)
36. Singh, A.B., and Harris, R.C. (2005). Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17,1183-1193. (Pubitemid 40984037)
37. Snedeker, S.M., Brown, C.F., and DiAugustine, R.P. (1991). Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 88, 276-280. (Pubitemid 21914470)
38. Spitzer, E., Zschiesche, W., Binas, B., Grosse, R., and Erdmann, B. (1995). EGF and TGF alpha modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: possible role of the arachidonic acid pathway. J Cell Biochem 57, 495-508 .
39. Taketarti, Y., and Oka, T. (1983). Biological action of epidermal growth factor and its functional receptors in normal mammary epithelial ceils. Proc Natl Acad Sci USA 80, 2647-2650.
40. Wells, A. (1999). EGF receptor. Int J Biochem Cell Biol 31, 637-643. (Pubitemid 29248872)
41. Zhao, X., Dai, W., Zhu, H., Zhang, Y., Cao, L., Ye, Q., Lei, P., and Shen, G. (2006). Epidermal growth factor (EGF) induces apo-physis in a transfected cell line expressing EGF receptor on its membrane. Cell Biol Int 30, 653-658. (Pubitemid 44209330)